 |
| |
| Dec-19-19 | Initiated |
Cantor Fitzgerald |
Overweight |
|
|
| Dec-18-19 | Initiated |
Cantor Fitzgerald |
Overweight |
|
|
| Nov-21-19 | Downgrade |
Morgan Stanley |
Equal-Weight → Underweight |
$17 → $6 |
|
| Nov-20-19 | Resumed |
Guggenheim |
Neutral |
|
|
| May-03-19 | Upgrade |
Wedbush |
Neutral → Outperform |
$26 |
|
| Apr-12-19 | Initiated |
Guggenheim |
Neutral |
|
|
| Feb-07-19 | Upgrade |
Citigroup |
Sell → Buy |
|
|
| Feb-07-19 | Downgrade |
Wedbush |
Outperform → Neutral |
|
|
| Feb-06-19 | Upgrade |
Raymond James |
Underperform → Mkt Perform |
|
|
| Feb-04-19 | Downgrade |
Citigroup |
Neutral → Sell |
$10 |
|
| Dec-10-18 | Downgrade |
Raymond James |
Outperform → Underperform |
|
|
| Sep-10-18 | Resumed |
BTIG Research |
Buy |
$30 |
|
| May-31-18 | Initiated |
Evercore ISI |
Outperform |
$33 |
|
| Mar-05-18 | Initiated |
H.C. Wainwright |
Buy |
$38 |
|
| Mar-31-17 | Initiated |
Raymond James |
Outperform |
$26 |
|
| Mar-02-17 | Initiated |
Instinet |
Buy |
$41 |
|
| Dec-20-16 | Initiated |
SunTrust |
Buy |
$30 |
|
| Aug-04-16 | Downgrade |
Citigroup |
Buy → Neutral |
|
|
| Oct-19-15 | Upgrade |
Citigroup |
Neutral → Buy |
|
|
| Sep-17-15 | Initiated |
Citigroup |
Neutral |
$31 |
|
|
|
| Feb-13-20 07:30AM | MacroGenics Announces Date of Fourth Quarter and Full Year 2019 Financial Results Conference Call GlobeNewswire |
| Feb-10-20 07:30AM | MacroGenics to Participate in Upcoming Investor Conferences GlobeNewswire +5.78% |
| Jan-14-20 03:12PM | Eli Lilly ends deal with NextCure worth up to $1.4B for the local biotech American City Business Journals |
| Jan-13-20 07:30AM | MacroGenics to Present at the J.P. Morgan Healthcare Conference GlobeNewswire |
| Jan-09-20 04:30PM | MacroGenics Outlines Corporate Priorities for 2020 GlobeNewswire |
| Jan-06-20 05:14PM | Intrexon will take the name of its subsidiary. That company just scored orphan status for a rare cancer drug. American City Business Journals |
| Dec-19-19 12:00PM | MacroGenics Announces Submission of Margetuximab Biologics License Application to U.S. FDA GlobeNewswire |
| Dec-11-19 10:00AM | MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium GlobeNewswire |
| Dec-09-19 03:05PM | MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting GlobeNewswire |
| Dec-07-19 08:35AM | The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling Benzinga |
| Nov-15-19 12:02PM | We Think MacroGenics (NASDAQ:MGNX) Needs To Drive Business Growth Carefully Simply Wall St. |
| Nov-13-19 04:55PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE |
| Nov-12-19 01:45PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SNDL, MGNX and OLLI ACCESSWIRE |
| 12:45PM | FILING FIRM ANNOUNCES DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| 10:59AM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, OSTK, RUHN and REZI GlobeNewswire |
| 10:29AM | TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire |
| 10:00AM | DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 PR Newswire |
| 09:36AM | CLASS ACTION UPDATE for SNDL, DBX, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
| 07:37AM | MacroGenics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile |
| 03:29AM | Edited Transcript of MGNX earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents |
| 02:00AM | MGNX DEADLINE TODAY: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts MacroGenics (MGNX) Investors of Todays Deadline to Move for Lead Plaintiff ACCESSWIRE |
| Nov-11-19 03:35PM | CLASS ACTION UPDATE for SNDL, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
| 03:21PM | MacroGenics Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile |
| 01:45PM | FILING FIRM ANNOUNCES DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| 12:15PM | SHAREHOLDER ALERT: UNIT MGNX QUAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
| 12:00PM | MGNX INVESTOR DEADLINE TOMORROW: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against MacroGenics, Inc. ACCESSWIRE |
| 10:40AM | DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE |
| 09:41AM | SHAREHOLDER ALERT: PUMP MGNX VRAY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire |
| 07:10AM | FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of Tomorrows Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE |
| Nov-10-19 12:00PM | 2-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm GlobeNewswire |
| 10:30AM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, SDC and CC ACCESSWIRE |
| Nov-09-19 07:35PM | 3-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE |
| 11:52AM | ROSEN, A LEADING GLOBAL LAW FIRM, Reminds MacroGenics, Inc. Investors of Important November 12th Deadline in Securities Class Action MGNX GlobeNewswire |
| Nov-08-19 08:15PM | 4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm ACCESSWIRE |
| 04:59PM | MGNX NOTICE: Zhang Investor Law Reminds Investors of November 12 Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX GlobeNewswire |
| 03:00PM | DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 GlobeNewswire |
| 02:15PM | CLASS ACTION UPDATE for SEE, MGNX and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
| 01:00PM | 4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE |
| 11:20AM | SHAREHOLDER ALERT: SEE UNIT MGNX UBER: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire |
| 10:40AM | SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Deadline: November 12, 2019 ACCESSWIRE |
| 10:23AM | MacroGenics Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm Newsfile |
| 09:50AM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, CVET and MYGN ACCESSWIRE |
| Nov-07-19 08:05PM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 5-Day Application Deadline is Approaching in Securities Class Action ACCESSWIRE |
| 05:30PM | SHAREHOLDER ALERT: COF MGNX CVET: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
| 04:45PM | MacroGenics to Participate in Upcoming Investor Conferences GlobeNewswire |
| 04:39PM | INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MGNX, ERI, and SNDL of Filing Deadlines GlobeNewswire |
| 02:15PM | CLASS ACTION UPDATE for UNIT, MGNX and MTCH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
| 01:30PM | 5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE |
| 09:25AM | CLASS ACTION UPDATE for PUMP, MGNX, IRBT and TWTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
| Nov-06-19 07:50PM | HAGENS BERMAN, SHAREHOLDER ADVOCATES, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 6-Day Application Deadline is Approaching ACCESSWIRE |
| 06:35PM | MacroGenics (MGNX) Reports Q3 Loss, Lags Revenue Estimates Zacks |
| 06:00PM | DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the Firm PR Newswire |
| 04:01PM | MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results GlobeNewswire |
| 03:30PM | SHAREHOLDER ALERT: SNDL MGNX TME: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
| 02:00PM | SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE |
| 01:30PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE |
| 12:15PM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MGNX, TME and UBER ACCESSWIRE |
| 10:39AM | SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE |
| 09:30AM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PUMP, MGNX, TME and UBER GlobeNewswire |
| 09:12AM | MacroGenics Announces Flotetuzumab Presentations at the ASH Annual Meeting 2019 GlobeNewswire |
| Nov-05-19 08:00PM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys Now, 7-Day Application Deadline is Approaching GlobeNewswire |
| 04:00PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of UNIT, MGNX and MO ACCESSWIRE |
| 03:15PM | FIRST FIRM TO FILE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| 11:00AM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MDP, MGNX and CVET ACCESSWIRE |
| 10:00AM | Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against MacroGenics, Inc. (MGNX) and November 12 Deadline Business Wire |
| Nov-04-19 08:05PM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies MacroGenics (MGNX) Investors of 8-Day Application Deadline, Encourages Investors Who Suffered Significant Losses to Contact Firm Now ACCESSWIRE |
| 04:00PM | IMPORTANT REMINDER FOR MACROGENICS, INC. INVESTORS: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the District of Maryland against MacroGenics, Inc. GlobeNewswire |
| 03:57PM | UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile |
| 03:10PM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FTCH, UNIT and MGNX ACCESSWIRE |
| 12:45PM | FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| 12:35PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX GlobeNewswire |
| 12:20PM | CLASS ACTION UPDATE for SNDL, MGNX and OSTK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
| 10:38AM | SHAREHOLDER ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: November 12, 2019 ACCESSWIRE |
| 09:37AM | 3 Medical Product Stocks Likely to Beat This Earnings Season Zacks |
| Nov-01-19 03:35PM | SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| 03:00PM | Shareholder Alert - Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Actions GlobeNewswire |
| 01:11PM | INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MGNX, ERI, and SNDL of Filing Deadlines GlobeNewswire |
| 12:14PM | CLASS ACTION UPDATE for MGNX, MO, MTCH and TWTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
| 11:29AM | Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX GlobeNewswire |
| 10:10AM | Investor Alert - Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement ACCESSWIRE |
| Oct-31-19 01:00PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, CC and TEUM ACCESSWIRE |
| 12:45PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| 11:40AM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX ACCESSWIRE |
| 09:41AM | CLASS ACTION UPDATE for ADTN, MDP, MGNX and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire |
| 07:00AM | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of Securities Class Action: Encourages Investors Who Have Suffered Losses to Contact Firm GlobeNewswire |
| Oct-30-19 05:25PM | CLASS ACTION UPDATE for MGNX, MTCH and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE |
| 04:05PM | MacroGenics Announces Date of Third Quarter 2019 Financial Results Conference Call GlobeNewswire |
| 04:00PM | Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, ViewRay, Cadence Bancorp, and ProPetro and Encourages Investors to Contact the Firm GlobeNewswire |
| 02:25PM | SHAREHOLDER ALERT: ADTN MGNX OSTK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
| 01:10PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| 10:45AM | SHAREHOLDER ALERT: COF MDP MGNX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
| 10:34AM | MacroGenics (MGNX) Expected to Beat Earnings Estimates: Should You Buy? Zacks |
| 10:09AM | Investor Alert- Greenlane Holdings, Inc. (GNLN), MacroGenics, Inc. (MGNX) & ViewRay, Inc. (VRAY) - Bronstein, Gewirtz & Grossman, LLC Class Actions ACCESSWIRE |
| Oct-29-19 08:00PM | SHAREHOLDER ALERT: COF MGNX MYGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE |
| 07:05PM | Notice of Lead Plaintiff Deadline for Shareholders in the Macrogenics, Inc. Securities Class Action Lawsuit Business Wire |
| 05:05PM | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SNDL, MGNX and CC ACCESSWIRE |
| 04:20PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
| Oct-28-19 09:55PM | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MGNX, OLLI and INFY ACCESSWIRE |
| 08:21PM | Is MacroGenics Inc (MGNX) Going To Burn These Hedge Funds ? Insider Monkey |
| 05:35PM | FIRST LAW FIRM TO FILE: The Schall Law Firm Files a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE |
|
|
|
|
| MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. Its pipeline of immuno-oncology product candidates includes Margetuximab, a monoclonal antibody, which is in Phase III clinical trial that targets HER2-expressing tumors, such as various breast and gastroesophageal cancers. The company is also developing Flotetuzumab, a DART molecule that recognizes CD123 and CD3; MGA012, an anti-PD-1 monoclonal antibody, which inhibits programmed cell death protein 1 (PD-1); MGD013, a monoclonal antibody that targets the immune checkpoints PD-1 and lymphocyte-activation gene 3; MGD019, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; and Enoblituzumab, a monoclonal antibody that targets B7-H3. In addition, the company is developing MGD009, a DART molecule that targets B7-H3 expressed on tumor cells and CD3; MGC018, an antibody drug conjugate, which targets solid tumors expressing B7-H3; and MGD007, a DART molecule, which targets glycoprotein A33 and CD3; and MGD014, a DART molecule that targets virus-infected cells. It has strategic collaborations with Incyte Corporation; Les Laboratoires Servier and Institut de Recherches Servier; and Zai Lab Limited. MacroGenics, Inc. was founded in 2000 and is headquartered in Rockville, Maryland. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 05 | Option Exercise | 0.94 | 623 | 586 | 33,091 | Feb 06 04:41 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 05 | Sale | 10.00 | 623 | 6,230 | 32,468 | Feb 06 04:41 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 04 | Option Exercise | 0.94 | 30 | 28 | 32,498 | Feb 06 04:41 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | Feb 04 | Sale | 10.00 | 30 | 300 | 32,468 | Feb 06 04:41 PM | | Karrels James | SVP, CFO and Secretary | Jan 30 | Option Exercise | 0.94 | 12,500 | 11,750 | 147,987 | Jan 31 04:45 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | Sep 27 | Option Exercise | 0.94 | 1,662 | 1,562 | 32,468 | Oct 03 04:33 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | May 22 | Option Exercise | 0.94 | 1,000 | 940 | 31,806 | May 22 04:21 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | May 22 | Sale | 19.03 | 1,000 | 19,026 | 30,806 | May 22 04:21 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | May 20 | Option Exercise | 0.94 | 3,000 | 2,820 | 33,806 | May 22 04:21 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | May 20 | Sale | 18.38 | 3,000 | 55,131 | 30,806 | May 22 04:21 PM | | Risser Eric Blasius | Sr VP & Chief Business Officer | Mar 14 | Option Exercise | 0.94 | 2,497 | 2,347 | 30,806 | Mar 18 04:36 PM |
|
|
|
|
|
|
